{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:55:07Z","timestamp":1789880107353,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jns.2013.10.029","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:46:11Z","timestamp":1383007571000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical spectrum and gender differences in a large cohort of Charcot\u2013Marie\u2013Tooth type 1A patients"],"prefix":"10.1016","volume":"336","author":[{"given":"C\u00e9cile","family":"Colomban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Gonnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Blin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Attarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000472166","article-title":"Estimation of the mutation frequencies in Charcot\u2013Marie\u2013Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study","volume":"4","author":"Nelis","year":"1996","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.jns.2013.10.029_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot\u2013Marie\u2013Tooth's disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.jns.2013.10.029_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(91)90613-4","article-title":"DNA duplication associated with Charcot\u2013Marie\u2013Tooth disease type 1A","volume":"66","author":"Lupski","year":"1991","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jns.2013.10.029_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0960-8966(91)90055-W","article-title":"Duplication in chromosome 17p11.2 in Charcot\u2013Marie\u2013Tooth neuropathy type 1A (CMT 1A). The HMSN Collaborative Research Group","volume":"1","author":"Raeymaekers","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"Pt 7","key":"10.1016\/j.jns.2013.10.029_bb0025","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/123.7.1516","article-title":"Neurological dysfunction and axonal degeneration in Charcot\u2013Marie\u2013Tooth disease type 1A","volume":"123","author":"Krajewski","year":"2000","journal-title":"Brain"},{"issue":"Pt 3","key":"10.1016\/j.jns.2013.10.029_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/120.3.465","article-title":"The phenotypic manifestations of chromosome 17p11.2 duplication","volume":"120","author":"Thomas","year":"1997","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1085-9489.2005.10112.x","article-title":"Charcot\u2013Marie\u2013Tooth disease type 1A: clinicopathological correlations in 24 patients","volume":"10","author":"Carvalho","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.jns.2013.10.029_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12031-007-9029-3","article-title":"Neuroactive steroid levels in a transgenic rat model of CMT1A neuropathy","volume":"34","author":"Caruso","year":"2008","journal-title":"J Mol Neurosci"},{"issue":"6","key":"10.1016\/j.jns.2013.10.029_bb0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10072-006-0722-8","article-title":"Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study","volume":"27","author":"Padua","year":"2006","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1529-8027.2008.00159.x","article-title":"Correlation between clinical\/neurophysiological findings and quality of life in Charcot\u2013Marie\u2013Tooth type 1A","volume":"13","author":"Padua","year":"2008","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"10.1016\/j.jns.2013.10.029_bb0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/01.wnl.0000176062.44360.49","article-title":"Quality of life in patients with Charcot\u2013Marie\u2013Tooth disease","volume":"65","author":"Vinci","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2013.10.029_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","article-title":"Ascorbic acid for Charcot\u2013Marie\u2013Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial","volume":"8","author":"Burns","year":"2009","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.jns.2013.10.029_bb0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1474-4422(09)70260-1","article-title":"Effect of ascorbic acid in patients with Charcot\u2013Marie\u2013Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Micallef","year":"2009","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jns.2013.10.029_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1474-4422(11)70025-4","article-title":"Ascorbic acid in Charcot\u2013Marie\u2013Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial","volume":"10","author":"Pareyson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2013.10.029_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-7-70","article-title":"Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial","volume":"7","author":"Verhamme","year":"2009","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.jns.2013.10.029_bb0080","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(09)70270-4","article-title":"Charcot\u2013Marie\u2013Tooth disease type 1A: is ascorbic acid effective?","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.jns.2013.10.029_bb0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ahj.2010.03.002","article-title":"Maximizing scientific knowledge from randomized clinical trials","volume":"159","author":"Gustafsson","year":"2010","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.jns.2013.10.029_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd3493","article-title":"Accelerating access to treatments for rare diseases","volume":"10","author":"Dunoyer","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2008.10.003","article-title":"Clinical research for rare disease: opportunities, challenges, and solutions","volume":"96","author":"Griggs","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.jns.2013.10.029_bb0100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","article-title":"Reliability and validity of the CMT neuropathy score as a measure of disability","volume":"64","author":"Shy","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2013.10.029_bb0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","article-title":"Neuropathy progression in Charcot\u2013Marie\u2013Tooth disease type 1A","volume":"70","author":"Shy","year":"2008","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jns.2013.10.029_bb0110","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.apmr.2007.07.011","article-title":"Development of a French isometric strength normative database for adults using quantitative muscle testing","volume":"88","author":"Hogrel","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.jns.2013.10.029_bb0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ana.410390610","article-title":"Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group","volume":"39","author":"Tawil","year":"1996","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jns.2013.10.029_bb0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.jns.2013.10.029_bb0125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale","volume":"77","author":"Graham","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.10.029_bb0130","doi-asserted-by":"crossref","first-page":"3S77-84","DOI":"10.1016\/S0035-3787(07)92164-5","article-title":"Dysimmune peripheral neuropathies: evaluation of treatment","volume":"163","author":"Nicolas","year":"2007","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.jns.2013.10.029_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nmd.2007.11.008","article-title":"Natural history of CMT1A including QoL: a 2-year prospective study","volume":"18","author":"Padua","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jns.2013.10.029_bb0140","series-title":"Sant\u00e9-2003 (version standard)-(2003) [fichier \u00e9lectronique], INSEE [producteur], Centre Maurice Halbwachs (CMH) [diffuseur]","author":"INSEE","year":"2003"},{"issue":"5","key":"10.1016\/j.jns.2013.10.029_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1191\/1352458502ms826oa","article-title":"Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment","volume":"8","author":"Vermersch","year":"2002","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.jns.2013.10.029_bb0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot\u2013Marie\u2013Tooth disease","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Pt 5","key":"10.1016\/j.jns.2013.10.029_bb0155","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/brain\/aws085","article-title":"Auditory function in children with Charcot\u2013Marie\u2013Tooth disease","volume":"135","author":"Rance","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00408-006-0053-9","article-title":"Disorders of pulmonary function, sleep, and the upper airway in Charcot\u2013Marie\u2013Tooth disease","volume":"185","author":"Aboussouan","year":"2007","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.jns.2013.10.029_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1513\/pats.200709-155MG","article-title":"The epidemiology of adult obstructive sleep apnea","volume":"5","author":"Punjabi","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"9252","key":"10.1016\/j.jns.2013.10.029_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(00)03614-X","article-title":"Charcot\u2013Marie\u2013Tooth disease and sleep apnoea syndrome: a family study","volume":"357","author":"Dematteis","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jns.2013.10.029_bb0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jnnp.2007.137679","article-title":"Increased prevalence of obstructive sleep apnoea in patients with Charcot\u2013Marie\u2013Tooth disease: a case control study","volume":"79","author":"Dziewas","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2013.10.029_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2474-9-134","article-title":"Carpal tunnel syndrome and the use of computer mouse and keyboard: a systematic review","volume":"9","author":"Thomsen","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.jns.2013.10.029_bb0185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.rehab.2012.02.005","article-title":"Pain assessment in Charcot\u2013Marie\u2013Tooth (CMT) disease","volume":"55","author":"Ribiere","year":"2012","journal-title":"Ann Phys Rehabil Med"},{"issue":"8","key":"10.1016\/j.jns.2013.10.029_bb0190","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.nmd.2008.05.015","article-title":"Factors that influence health-related quality of life in Australian adults with Charcot\u2013Marie\u2013Tooth disease","volume":"18","author":"Redmond","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.jns.2013.10.029_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ageing\/26.1.15","article-title":"Comfortable and maximum walking speed of adults aged 20\u201379years: reference values and determinants","volume":"26","author":"Bohannon","year":"1997","journal-title":"Age Ageing"},{"issue":"12","key":"10.1016\/j.jns.2013.10.029_bb0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.nmd.2010.08.001","article-title":"168th ENMC International Workshop: outcome measures and clinical trials in Charcot\u2013Marie\u2013Tooth disease (CMT)","volume":"20","author":"Reilly","year":"2010","journal-title":"Neuromuscul Disord"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13029754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13029754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:42:48Z","timestamp":1758382968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13029754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022510X13029754"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.10.029","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical spectrum and gender differences in a large cohort of Charcot\u2013Marie\u2013Tooth type 1A patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}